Loading...
Loading...
CRL| Name | Value |
|---|---|
| Revenues | 1,026.1M |
| Cost of Revenue | 690.7M |
| Gross Profit | 335.5M |
| Operating Expense | 165.9M |
| Operating I/L | 169.6M |
| Other Income/Expense | -32.0M |
| Interest Income | 3.0M |
| Pretax | 119.7M |
| Income Tax Expense | 25.4M |
| Net Income/Loss | 90.0M |
Charles River Laboratories International, Inc. is a non-clinical contract research organization that provides drug discovery, non-clinical development, and safety testing services globally. The company operates through three segments: Research Models and Services, Discovery and Safety Assessment, and Manufacturing Solutions. It offers research model strains, in vivo discovery services, safety assessment services, and in vitro methods for quality control testing of pharmaceuticals and consumer products. Additionally, it provides specialized testing of biologics and avian vaccine services. The company generates revenue by selling research models, offering discovery and safety assessment services, and providing in vitro testing for pharmaceutical and consumer products.
